Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in Hong Kong with limited liability)

(Stock Code: 648) UPDATE ON TRADING ARRANGEMENT - SHARE CONSOLIDATION AND CHANGE IN BOARD LOT SIZE

Reference is made to the circular (the "Circular") of the Company dated 1 November 2017 relating to the Share Consolidation and the change in board lot size for trading in the Shares and the announcement (the "Announcement") of the Company dated 27 November 2017 relating to the suspension of trading in the Shares. Unless otherwise stated herein, capitalised terms used in this announcement shall have the same meaning as those defined in the Circular and the Announcement.

As disclosed in the Circular, parallel trading in the Consolidated Shares in both (i) the original counter (stock code: 648, stock short name: WAH YAN-NEW) in the form of new share certificates (light blue colour) in board lot of 5,000 Consolidated Shares; and (ii) the temporary counter (stock code: 2906, stock short name: WAH YAN-OLD) in the form of existing share certificate (light yellow colour) in board lot of 125 Consolidated Shares would commence at 9:00 a.m. on Monday, 4 December 2017. Given the suspension of trading in the Shares, the Company announces that parallel trading in the Consolidated Shares will be extended to a date on which trading in the Shares is resumed, but free exchange of existing certificates for new share certificates shall continue.

The Company will make further announcement(s) relating to the details of the trading arrangement of the Consolidated Shares as and when appropriate in compliance with the Listing Rules.

By Order of the board of directors of China Wah Yan Healthcare Limited Lam Sung Him Gaston

Company Secretary

Hong Kong, 30 November 2017

As at the date of this announcement, the board of directors of the Company comprises three executive directors, namely Mr. Chan Ka Chung, Mr. Cheung Wai Kwan and Mr. Wang Jianguo; and three independent non-executive directors, namely, Mr. Chan Yee Ping, Michael, Ms. Hu Xuezhen and Mr. Lam Chun Ho.

China Wah Yan Healthcare Limited published this content on 30 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 30 November 2017 13:21:02 UTC.

Original documenthttp://www.chinawahyan.com/upload/AC/2017/e_20171130.pdf

Public permalinkhttp://www.publicnow.com/view/980EBFEC1110C4DAFC658C6DFCCF0856AE42CCF6